Unit of Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, Finland.
Paediatric Growth and Endocrine Department, Hirabai Cowasji Jehangir Medical Research Institute, Pune, India.
BMC Pregnancy Childbirth. 2023 Aug 15;23(1):586. doi: 10.1186/s12884-023-05907-9.
The impact of pre-pregnancy weight and the rate of gestational weight gain (GWG) together on the risk of early GDM (< 24 weeks gestation; eGDM) has not been studied in the Indian context. We aimed to study the influence of (1) pre-pregnancy weight on the risk of eGDM diagnosed in two time intervals; and (2) in addition, the rate of GWG by 12 weeks on the risk of eGDM diagnosed in 19-24 weeks.
Our study utilized real-world clinical data on pregnant women routinely collected at an antenatal care clinic at a private tertiary hospital, in Pune, India. Women registering before 12 weeks of gestation (v), with a singleton pregnancy, and having a follow-up visit between 19-24 weeks (v) were included (n = 600). The oral glucose tolerance test was conducted universally as per Indian guidelines (DIPSI) at v and v for diagnosing eGDM. The data on the onset time of eGDM were interval censored; hence, we modeled the risk of eGDM using binomial regression to assess the influence of pre-pregnancy weight on the risk of eGDM in the two intervals. The rate of GWG by 12 weeks was added to assess its impact on the risk of eGDM diagnosed in v.
Overall, 89 (14.8%) women (age 32 ± 4 years) were diagnosed with eGDM by 24 weeks, of which 59 (9.8%) were diagnosed before 12 weeks and 30 of 541 (5.5%) women were diagnosed between 19-24 weeks. Two-thirds (66%) of eGDM were diagnosed before 12 weeks of gestation. Women's pre-pregnancy weight was positively associated with the risk of GDM in both time intervals though the lower confidence limit was below zero in v. The rate of GWG by 12 weeks was not observed to be associated with the risk of eGDM diagnosed between 19-24 weeks of gestation. These associations were independent of age, height, and parity.
Health workers may focus on pre-pregnancy weight, a modifiable risk factor for eGDM. A larger community-based study measuring weight and GDM status more frequently may be warranted to deepen the understanding of the role of GWG as a risk factor for GDM.
孕前体重和孕期体重增加率(GWG)对早发性妊娠期糖尿病(<24 周妊娠;eGDM)风险的综合影响在印度人群中尚未得到研究。本研究旨在探讨(1)孕前体重对两个时间间隔内 eGDM 发病风险的影响;以及(2)此外,GWG 在 12 周时的速率对 19-24 周时 eGDM 发病风险的影响。
我们的研究利用了印度浦那一家私立三级医院产前保健诊所常规收集的孕妇真实临床数据。登记时妊娠 12 周前(v)、单胎妊娠且在 19-24 周(v)有随访的孕妇被纳入研究(n=600)。根据印度指南(DIPSI),所有孕妇均进行口服葡萄糖耐量试验以诊断 eGDM。eGDM 的发病时间数据为区间 censored;因此,我们使用二项回归模型评估孕前体重对两个时间间隔内 eGDM 发病风险的影响。此外,我们还加入了 GWG 在 12 周时的速率以评估其对 v 时 eGDM 发病风险的影响。
总体而言,600 名孕妇中有 89 名(14.8%)在 24 周时被诊断为 eGDM,其中 59 名(9.8%)在 12 周前被诊断,30 名(5.5%)在 19-24 周时被诊断。eGDM 中有三分之二(66%)在 12 周前被诊断。尽管 v 时的置信下限低于零,但孕前体重与两个时间间隔内 GDM 的发病风险呈正相关。GWG 在 12 周时的速率与 19-24 周时的 eGDM 发病风险无关。这些关联独立于年龄、身高和产次。
卫生工作者可能会关注孕前体重,这是 eGDM 的一个可改变的危险因素。可能需要进行更大规模的基于社区的研究,以更频繁地测量体重和 GDM 状况,从而深入了解 GWG 作为 GDM 危险因素的作用。